Zobrazeno 1 - 8
of 8
pro vyhledávání: '"M N Zenina"'
Autor:
S V Gritsaev, I I Kostroma, G M Ryadnova, S A Tiranova, Zh V Chubukina, V A Balashova, M N Zenina, I S Martynkevich, N A Potikhonova, K M Abdulkadyrov
Publikováno v:
Терапевтический архив, Vol 87, Iss 7, Pp 97-100 (2015)
This rare type of acute leukemia, blast cells of which express myeloid and/or lymphoid markers, is mainly diagnosed using flow cytometric findings. The paper describes a clinical case of mixed-phenotype acute leukemia, in which B-cell lymphoid antige
Externí odkaz:
https://doaj.org/article/0c420ee9fa5f44e8b8fb4a4f38fab805
Autor:
N. A. Romanenko, S. S. Bessmeltsev, V. I. Rugal, N. A. Potichonova, M. N. Zenina, K. M. Abdulkadirov
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 61-68 (2022)
Case report of a patient with simultaneously developed lymphoid and myeloid hemoblastosis is presented. Diagnosis of multiple myeloma and chronic idiopathic myelofibrosis are confirmed by complete blood count, myelogramm, trephinebiopsy, immunohistoc
Externí odkaz:
https://doaj.org/article/716204851850427bb65131afee47f38e
Autor:
S. V. Voloshin, S. Yu. Linnikov, A. D. Garifullin, A. A. Kuzyaeva, A. V. Shmidt, A. Yu. Kuvshinov, A. N. Bogdanov, M. A. Mikhileva, I. S. Martynkevich, M. N. Zenina, S. V. Sidorkevich
Publikováno v:
Онкогематология, Vol 17, Iss 1, Pp 26-36 (2022)
Background. Over the past 15 years, the therapeutic breakthrough in the treatment of multiple myeloma observed primarily due to the emergence of new drugs. Since the characteristic of the disease is a chronic course with consecutive periods of remiss
Externí odkaz:
https://doaj.org/article/950e83cca2944d5084a1c58c5bd58213
Autor:
V. A. Shuvaev, M. S. Fominykh, I. S. Martynkevich, V. Y. Udaleva, N. A. Potikhonova, M. N. Zenina, K. M. Abdulkadyrov
Publikováno v:
Онкогематология, Vol 8, Iss 4, Pp 7-12 (2014)
At present, introduction of target therapy to chronic myelogenous leukemia (CML) treatment made CML not life-limiting disorder. The main condition of treatment efficacy is its continuity. The most common causes of dose reduction and CML therapy inter
Externí odkaz:
https://doaj.org/article/6386b1fc13004cc0a3c2a849d453ad09
Publikováno v:
Medical alphabet. 3:22-25
Diagnosis of hereditary spherocytosis, as the most common form of membranopathy, is improved, thanks to advances in biotechnology and the presence of a large number of modern automatic analyzers. All this leads to a reduction in the number of patient
Autor:
A. M Radzhabova, S. V Voloshin, I. S Martynkevich, A. A Kuzyaeva, VA. Shuvaev, E. V Motyko, A. Y Kuvshinov, M. S Fominykh, A. V Schmidt, L. B Polushkina, M. P Bakay, S. A Tiranova, M. N Zenina, N. A Potihonova, SA. Kudryashova, V. A Balashova, J. V Chubukina, O. S Uspenskaya, E. V Karyagina, A. N Bogdanov, A. V Chechetkin
Publikováno v:
Genes & Cells. 14:55-61
Detection of FLT3 gene mutations in acute myeloid leukemia is now recognized as an unfavorable factor that affects the disease course, emerging the risk of relapses and overall survival shortening and disease-free survival of patients. The aim of the
Autor:
V N, Stefanova, M N, Zenina
Publikováno v:
Tsitologiia. 56(10)
Automated chromosome classification is an essential task in cytogenetics of animals and plants. Until now the automatic karyotyping systems were obtained only for human chromosomes. The main aim of this study was to develop the automatic pig chromoso
Autor:
N A, Romanenko, S S, Bessmel'tsev, V Iu, Udal'eva, M N, Zenina, I S, Martynkevich, V I, Rugal', K M, Abdulkadyrov
Publikováno v:
Voprosy onkologii. 59(2)
The article describes the clinical observation of a patient with simultaneous course of lymphoid and myeloid neoplasms. The patient developed two diseases--chronic myeloid leukemia (CML) and multiple myeloma (MM), which were confirmed by corroborated